主要文件

查看所有文档

A9010

Ethyl arachidate

Name: Ethyl arachidate
Brand: SIGMA

≥99%

别名:

Ethyl eicosanoate, Ethyl ester of eicosanoic acid, Arachidic acid ethyl ester

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₂₂H₄₄O₂

化学文摘社编号:

18281-05-5

分子量:

340.58

NACRES:

NA.25

PubChem Substance ID:

24891396

UNSPSC Code:

12352211

MDL number:

MFCD00056233

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

biological source

synthetic (organic)

Quality Level

200

assay

≥99%

form

solid

functional group

ester

lipid type

omega FAs

shipped in

ambient

storage temp.

−20°C

SMILES string

CCCCCCCCCCCCCCCCCCCC(=O)OCC

InChI

1S/C22H44O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h3-21H2,1-2H3

InChI key

YBKSMWBLSBAFBQ-UHFFFAOYSA-N

说明

Application

Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.: This study explores the development of nanoparticles that can cross the blood-brain barrier to deliver anticancer drugs directly to glioblastoma, utilizing ethyl arachidate in their composition to enhance drug encapsulation and targeting (Ahmed et al., 2021).

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

0000547747

0000501546

0000498445

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.

Samara R Alves Rico et al.

Nanoscale, 9(30), 10701-10714 (2017-07-06)

A unique class of diruthenium(ii,iii) metallodrugs containing non-steroidal anti-inflammatory drug (NSAID), Ru

Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells.

Samara Rodrigues Alves et al.

Journal of inorganic biochemistry, 205, 110984-110984 (2020-01-14)

Novel formulations of diruthenium(II,III)-NSAID (NSAID, non-steroidal anti-inflammatory drug) metallodrugs encapsulated into biocompatible terpolymer-lipid nanoparticles (TPLNs) to target glioblastoma cancer were developed. The nanoformulations of Ibuprofenate (RuIbp) and Naproxenate (RuNpx) metallodrugs were synthesized and characterized. The procedure rationally designed to avoid

Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.

Tian Zhang et al.

Advanced healthcare materials, 8(18), e1900543-e1900543 (2019-07-28)

Patients with brain metastases of triple negative breast cancer (TNBC) have a poor prognosis owing to the lack of targeted therapies, the aggressive nature of TNBC, and the presence of the blood-brain barrier (BBB) that blocks penetration of most drugs.

全球贸易项目编号

货号	GTIN
A9010-1G	04061833401156
A9010-10G	04061833608241

主要文件

Ethyl arachidate

≥99%

选择尺寸

关于此项目

biological source

Quality Level

assay

form

functional group

lipid type

shipped in

storage temp.

SMILES string

InChI

InChI key

Application

安全信息

存储类别

wgk

flash_point_f

flash_point_c

ppe

文件

分析证书(COA)

已有该产品？

同行评审论文

全球贸易项目编号